Skip to main content

Peer Review reports

From: Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasia

Original Submission
5 Dec 2017 Submitted Original manuscript
18 Dec 2017 Author responded Author comments - Lei Li
Resubmission - Version 2
18 Dec 2017 Submitted Manuscript version 2
7 Mar 2018 Reviewed Reviewer Report - Catherine M. Popadiuk
12 Mar 2018 Reviewed Reviewer Report - Brian Slomovitz
19 Mar 2018 Reviewed Reviewer Report - John Lurain
22 Mar 2018 Author responded Author comments - Lei Li
Resubmission - Version 3
22 Mar 2018 Submitted Manuscript version 3
24 Mar 2018 Reviewed Reviewer Report - John Lurain
27 Mar 2018 Reviewed Reviewer Report - Catherine M. Popadiuk
29 Mar 2018 Reviewed Reviewer Report - Brian Slomovitz
14 May 2018 Author responded Author comments - Lei Li
Resubmission - Version 4
14 May 2018 Submitted Manuscript version 4
Publishing
16 May 2018 Editorially accepted
23 May 2018 Article published 10.1186/s12885-018-4512-5

You can find further information about peer review here.

Back to article page